Randall E. Kaye
2022
In 2022, Randall E. Kaye earned a total compensation of $1.4M as Executive Vice President and Chief Medical Officer at Longboard Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $198,000 |
|---|---|
| Option Awards | $827,115 |
| Salary | $351,563 |
| Other | $9,150 |
| Total | $1,385,828 |
Kaye received $827.1K in option awards, accounting for 60% of the total pay in 2022.
Kaye also received $198K in non-equity incentive plan, $351.6K in salary and $9.2K in other compensation.
Rankings
In 2022, Randall E. Kaye's compensation ranked 2,400th out of 5,760 executives tracked by ExecPay. In other words, Kaye earned more than 58.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,400 out of 5,760 | 58th |
Division Manufacturing | 1,319 out of 3,136 | 58th |
Major group Chemicals And Allied Products | 589 out of 1,422 | 59th |
Industry group Drugs | 544 out of 1,323 | 59th |
Industry Pharmaceutical Preparations | 394 out of 969 | 59th |
Source: SEC filing on April 11, 2023.
Kaye's colleagues
We found two more compensation records of executives who worked with Randall E. Kaye at Longboard Pharmaceuticals in 2022.